High-Dose Omega-3 Supplements Found to Increase A-fib Risk

If you use these supplements, you should take aggressive lifestyle measures to lower the likelihood of developing this abnormal heart rhythm.

0
In the March issue, we introduced the landmark clinical trial of Epanova, a new prescription drug containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in four times the dose found in over-the-counter omega-3 supplements. In this trial, called STRENGTH, the stronger supplements were no better than placebo at protecting against cardiovascular death, nonfatal heart attack […]
To continue reading this article or issue you must be a paid subscriber

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
 
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

LEAVE A REPLY

Please enter your comment!
Please enter your name here